NEW YORK--(BUSINESS WIRE)--OMRIX Biopharmaceuticals, Inc. (“OMRIX” or the “Company”) (NASDAQ: OMRI), a fully-integrated biopharmaceutical company that develops and markets biosurgical and immunotherapy products, today announced that it will webcast its Analyst and Investor Day, which will be held on Thursday, March 27, 2008 at the NASDAQ MarketSite in New York City. The opening presentation will begin promptly at 8:00 a.m. ET and the event will conclude at 12:30 p.m. ET.
